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ABSTRACT
Development of efficient and reproducible conditions for directed differentiation of pluripotent stem
cells into specific cell types is important not only to understand early human development but also to
enablemore practical applications, such as in vitro diseasemodeling, drugdiscovery, and cell therapies.
The differentiation of stem cells to retinal pigment epithelium (RPE) in particular holds promise as a
source of cells for therapeutic replacement in age-related macular degeneration. Here we show devel-
opmentofanefficientmethodforderivinghomogeneousRPEpopulations inaperiodof45daysusingan
adherent,monolayer systemanddefinedxeno-freemediaandmatrices. Themethodutilizes sequential
inhibition and activation of the Activin and bonemorphogenetic protein signaling pathways and can be
applied to both human embryonic stem cells and induced pluripotent stem cells as the starting popu-
lation. In addition, we use whole genome transcript analysis to characterize cells at different stages of
differentiation that provides further understanding of the developmental dynamics and fate specifica-
tionofRPE.Weshow thatwith thedescribedmethod, RPE develop through stages consistentwith their
formation during embryonic development. This characterization— together with the absence of steps
involving embryoid bodies, three-dimensional culture, or manual dissections, which are common fea-
tures of other protocols—makes this process very attractive for use in research as well as for clinical
applications. STEM CELLS TRANSLATIONAL MEDICINE 2016;5:1–12
SIGNIFICANCE
This report describes a novel method of directed differentiation to generate retinal pigment epithe-
lium (RPE) cells from pluripotent stem cells. The employed method is based on adherent monolayer
culture using xeno-free conditions andmanipulation of the Activin and bonemorphogenetic protein
signaling pathway using small molecules and recombinant proteins.Whole genomemicroarray anal-
ysis was performed to characterize the differentiation process and understand the developmental
path of RPE generation in vitro. Thismethod can be applied for generation of RPE for research as well
as for clinical applications.
INTRODUCTION
Age-related macular degeneration (AMD) is a
leading cause of irreversible vision loss among
the elderly population in the developed world
[1]. The primary cell type affected in this disease
is the retinal pigment epithelium (RPE). RPE cells
are situated as amonolayer beneath the photore-
ceptors and perform several important functions
to maintain the visual cycle, for example, metab-
olism and storage of retinoid, phagocytosis of rod
outer segments, absorption of scattered light,
barrier activity, and ion transport [2]. Degenera-
tion of RPE in AMD results in subsequent loss of
photoreceptors, leading to loss of vision. AMD
manifests in two forms: the exudative orwet type
and the dry type [3].Wet AMD is characterized by
neovascularization of the choroid and can be con-
trolledwith intravitreal injections of anti-vascular
endothelial growth factor (VEGF) antibodies,
small molecule inhibitors, or both. The dry type
is more common, representing themajority of in-
dividuals with AMD, for which there are no ther-
apies available at present. An approach that is
currently under substantial investigation is the re-
placement of dysfunctional, diseased RPE with
cells derived in vitro from stem cell differentia-
tion. Preclinical as well as early clinical reports
suggest that this strategy is safe and allows the
newly transplanted RPE to effectively perform
functions such as phagocytosis, fluid and nutrient
transport, and photoreceptor support, leading to
potential restoration of vision [4–7]. In addition,
there are many features that make the eye an
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attractive organ for cell replacement and regenerative therapy
approaches, such as the requirement of fewer cells for therapeu-
tic intervention in comparison with other larger organs, accessi-
bility and ease of monitoring, potential immune privilege, and
presence of the retinal-blood barrier, leading to separation from
systemic circulation [8]. Therefore, there has been considerable
interest in developing protocols to generate RPE cells fromplurip-
otent stem cells with high efficiency and purity to use for trans-
plantation as well as to study AMD disease mechanisms.
Although several protocols describing differentiation of RPE
fromhumanembryonic stemcells (hESC) andhuman inducedplu-
ripotent stem cells (hiPSC) have been described, they often have
limitations, including low yield, high variability, or steps involving
embryoid bodies, cysts, or eye cup structures, togetherwithman-
ual excision of pigmented cells [9, 10]. These limitations are un-
desirable for scale-up and transfer to a good manufacturing
practice (GMP) clinical manufacturing setting. Therefore, we
aimed to develop a robust, adherent monolayer-based directed
differentiation protocol to generate RPE from pluripotent stem
cells with high efficiency, with high yield, and in short time scales.
We have applied knowledge of development of the vertebrate
nervous system, inwhich temporal and spatial gradients of signal-
ingmolecules interact to regulate tissue formation, todevise an in
vitro protocol for RPE differentiation that mimics developmental
cues. The bone morphogenetic protein (BMP) and Activin/Nodal
signaling pathways play important roles in development and
specification of RPE fate. First, the neuroectoderm is specified
by inhibition of BMP and Activin/Nodal signaling [11, 12], which
then further differentiates into eye field and RPE in a process
requiring sequential activation of BMP and Activin signaling
[9, 13–16]. We have utilized this feature of dynamic activation
and repression of these pathways for development of our
method. Furthermore, we performmicroarray profiling to under-
stand the identity of the cells at the population level across all
stages of our protocol. This allows us to identify key features of
the differentiation aswell as understand purity of the population,
which can beused to design strategies for quality control and pro-
cess development for clinical manufacturing applications.
MATERIALS AND METHODS
Directed Differentiation of Pluripotent Stem Cells
Toward RPE
All work was carried out in a sterile biological safety cabinet.
hESC (SHEF1; WA26) or hiPSC (AD3.1; SendaiF, which refers to
erythroblasts reprogrammedusing the CytoTune-iPS Reprogram-
ming kit; Thermo Fisher Scientific Life Sciences, Waltham, MA,
http://www.thermofisher.com) were routinely cultured on hu-
man recombinant vitronectin (Thermo Fisher) in Essential 8 me-
dium (Thermo Fisher) or on hESC-qualified Matrigel (Corning,
Manassas, VA, https://www.corning.com) in mTeSR1 medium
(STEMCELL Technologies, Vancouver, BC, Canada, https://
www.stemcell.com). A schematic of the differentiation pro-
cess is shown in Figure 1. Pluripotent cells were treated with
10 mM Y-27632 ROCK inhibitor (Tocris Bioscience, Bristol,
U.K., https://www.tocris.com) for 1 hour prior to dissociation.
The cells were dissociated with Accutase (Thermo Fisher) and
passed through a 40-mm cell strainer to remove larger aggre-
gates. Cells were seeded at a density of 240,000 cells per
cm2 onto T25 flasks (Nunclon; Thermo Fisher) or 96-well plates
(Corning CellBIND) coatedwithmatrices, for example, growth fac-
tor reducedMatrigel (Corning) or humanplasma-derived fibronec-
tin (Sigma-Aldrich, St. Louis, MO, https://www.sigmaaldrich.com)
in E8 or TeSR2 (STEMCELL Technologies)medium containing 5mM
Y-27632. The next day (day 1), culture mediumwas changed to E8
or TeSR2without Y-27632. On day 2, cells were switched to Induc-
tionMedium1:Dulbecco’smodifiedEagle’smedium (DMEM)KSR-
XF(KnockOutDMEMmedium[ThermoFisher], supplementedwith
20% KnockOut Serum Replacement Xeno-Free [Thermo Fisher],
1% b-Mercaptoethanol [Sigma-Aldrich], 1% GlutaMax [Thermo
Fisher], and1%non-essential aminoacid solution [ThermoFisher]),
supplemented with two inhibitors (LDN/SB): 1 mM LDN-193189
(Stemgent, Cambridge, MA, https://www.stemgent.com) and
10 mM SB-431542 (Sigma-Aldrich). Induction Medium 1 was
replenished daily for 4 days (day 2 to day 5). On day 6, culture me-
diumwas switched to InductionMedium2:DMEMKSR-XF, supple-
mentedwith 100 ng/ml BMP4/7 (R&DSystems,Minneapolis,MN,
https://www.rndsystems.com)for3days. Theculturemediumwas
replenished every day up to day 9. The period fromday 0—that is,
at the point of seeding pluripotent cells to day 9—is referred to as
stage 1 for the remainder of this article. On day 9, the cells were
replated. The cultures were pretreated with 10 mM Y-27632 for
35 min, dissociated by using Accutase, passed through a 40-mm
cell strainer, and seeded at a density of 320,000 cells per cm2 on
Matrigel- or CELLStart- (Thermo Fisher) coated surfaces. Cellswere
treated with Induction Medium 3: DMEM KSR-XF, supplemented
with 100 ng/ml Activin A (ActA; R&D Systems). The Induction Me-
dium3wasreplenished three timesaweekuntil day28. Thisperiod
of the protocol, from day 9 to day 28, is referred to as stage 2. On
day 28, cells were dissociated with Accutase, passed through a
70-mm cell sieve and plated at a density of 100,000 cells per cm2
on CELLStart-coated surfaces. The replated cells were replenished
with DMEM KSR-XF twice a week for at least 14 days, that is, until
day 42, before the identity and purity of the cells were assessed by
various methods. This stage of the protocol, from day 28 to day 42
andbeyond, is referred toasstage3.For cultureonpolyestermem-
brane in transwell culture inserts, cells fromtheendof stage3were
dissociated and replated on Vitronectin-coated polyester trans-
wells at a density of 360,000 cells per cm2. The replated cells were
replenishedwith DMEMKSR-XF twice a week, and themedia from
the top and bottom compartments were kept separate. Spentme-
diumwas collected for further analysis of secreted factors by using
commercially available enzyme-linked immunosorbent assay kits
(MS6000, human VEGF pigment epithelium-derived factor [PEDF]
duplex assay) on theMesoscale discovery platform.Beadphagocy-
tosis assaywas performedwith polystyrenemicrospheres (1.0-mm
Red FluoSpheres; Thermo Fisher), following a published protocol
[17]. RPE were generated from hESC by spontaneous differentia-
tion with a protocol described previously [18].
RNA Extraction, cDNA Synthesis, and Quantitative
Polymerase Chain Reaction
Total RNA was extracted from RPE cells using the RNeasy Mini or
Micro Kit (Qiagen, Hilden, Germany, https://www.qiagen.com)
with on-column DNase digestion. cDNA was synthesized using
the High Capacity cDNA Synthesis kit (Thermo Fisher). Individual
gene expression was assessed using predesigned Taqman assays
(Thermo Fisher) and the reactions were carried out on the CFX96
iCycler platform (Bio-Rad, Raleigh, NC, https://www.bio-rad-
antibodies.com). Gene expression in all instances was quantified
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by the relativequantificationmethodof22DDCt andnormalized to
geometric means of at least two housekeeping genes.
Microarray Analysis
mRNA was hybridized on Illumina HT-12v4 BeadChips according
to themanufacturer’s instructions. Themicroarray data are avail-
able in the ArrayExpress database under accession number
E-MTAB-4259. Raw datawere log2 transformed and quantile nor-
malized with R/Biocondcutor and the lumi and beadarray pack-
ages. Principal components analysis (PCA) was performed using
the pcaMethods package. Differential expression between time
points was performed using the limma package with a multiple
testing adjusted p value cutoff of p, .01.
Immunocytochemistry
Samples were fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS) for 15 min followed by blocking and perme-
abilization using 0.3% Triton X-100 in PBS and 10% normal donkey
serum. Primary antibodies used in this study are anti-PMEL17
(Dako, Carpinteria, CA, http://www.dako.com, M0634), anti-ZO1
(Thermo Fisher, 187430), anti-CRALBP (Affinity Biosciences, Cam-
bridge, U.K., http://www.affbiotech.com, MA1-813), anti-OCT4
(Santa Cruz Biotechnology, http://www.scbt.com, sc-8628), anti-
Pax6 (Covance, Princeton, NJ, http://www.covance.com, PRB-
278P), anti-MITF (Thermo Fisher,MS-772-PABX), anti-Otx2 (Merck
Millipore, Darmstadt, Germany, http://www.emdmillipore.com,
ab9566), anti-Lhx2 (Santa Cruz Biotechnology, sc-19344), and
anti-b Crystallin (Abcam, Cambridge, U.K., http://www.abcam.
com, ab151722). Nuclei were counterstained with the nuclear
dye Hoechst. Images were captured and analyzed on the ImageX-
press platform (Molecular Devices, Sunnyvale, CA, https://www.
moleculardevices.com) or an epifluorescentmicroscope (Carl Zeiss
AG, Oberkochen, Germany, http://www.zeiss.com).
RESULTS
Dual SMAD Inhibition Followed by BMP Pathway
Activation Leads to Differentiation of Pluripotent Stem
Cells to Eye Field
Previous work from our group has demonstrated the efficient in-
duction of anterior neuroectoderm (ANE) from pluripotent stem
cells using small molecule inhibitors of the bone morphogenetic
protein (BMP) andActivin/Nodal signaling armsof the TGFbpath-
way [11]. Activin/Nodal signaling leads to phosphorylation of
SMAD2/3 through the action of ALK4/5/7 kinases, whereas
BMP signaling leads to phosphorylation of SMAD1/5/8 through
ALK2/3 kinases. We have shown that use of 10 mM SB-431642
(SB) and 1 mM LDN-193189 (LDN) leads to effective inhibition
of the Activin/Nodal and BMP signaling pathways, resulting in
downstream “dual SMAD” inhibition. This directs the pluripotent
stem cells toward the ANE fate efficiently and homogeneously.
Furthermore, dual SMAD inhibition has been shown to increase
RPE yield using the spontaneous differentiation method, indicat-
ing that this mechanism is involved in RPE differentiation [19].
Therefore, wewanted to extend these observations to further di-
rect the ANE state toward eye field specification and RPE forma-
tion in a controlledmanner. Knowledge of developmental biology
from zebrafish, chick, and rodent models informs us that the re-
gionalization of the ANE toward the forebrain, and further spec-
ificationof the forebrain cells towardeye field is achieved through
the temporal induction of BMP signaling [13–15]. Hence, we in-
vestigatedwhether treatment of cells at theANE stagewith BMPs
would lead to increased expression of eye field features.
To initiate differentiation, we seeded SHEF1 hESC as single dis-
sociated cells. After 2 days (day 2), when the cells reach 80%–90%
confluence, theculturemediumwaschangedto InductionMedium
supplementedwith SB and LDN (InductionMedium1). Dual SMAD
inhibitionwasmaintained for 4 days. At this point, that is, at day 6,
LDN/SB were withdrawn, and the cells were treated with the
BMP4/7 recombinant heterodimer (InductionMedium 2) for a pe-
riod of 3 days. At day 9, immunocytochemistry was carried out to
assessexpressionofkeyeye-field transcription factors. Therewas a
markeddownregulationof thepluripotencymarkerOCT4 together
with uniform induction of eye field markers such as LHX2, SOX11,
PAX6, and MITF upon this sequential inhibition of Activin/BMP
pathways followed by BMP activation, in comparison with nonin-
ducedcells (Fig.2A).Similar resultswereobtainedusingahiPSC line
(SendaiF) as the starting material (supplemental online Fig. 1). To
determinewhether theobservedeffectwas specific to theBMP4/7
heterodimer, we tested the individual BMP4 andBMP7proteins in
parallelwith theBMP4/7heterodimerandmeasuredexpressionof
Mitf transcript. Similar results were seen under all conditions (Fig.
2B) and 100 ng/ml BMP4/7 heterodimer was used for the remain-
der of the work, because it has been shown to bemore potent for
BMP signaling activation in other systems [20, 21].
Efficient Differentiation of the Eye Field Toward RPE
Requires Replating in the Presence of Activin A
Once the eye field develops, it is further specified toward the
RPE lineage by Activin A (ActA) signaling, which is thought to
Figure1. Directeddifferentiationofstemcells toretinalpigmentepithelium.Schematicof thedirecteddifferentiationprotocoldescribed in thisstudy.
p, replating steps. Abbreviations: ANE, anterior neuroectoderm; BMP, bone morphogenetic protein; RPE, retinal pigment epithelium; hESC, human
embryonic stem cells; hiPSC, human induced pluripotent stem cells; RPE, retinal pigment epithelium; SMADi, inhibitor of SMAD pathway.
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be secreted by the mesenchyme neighboring the optic vesicle
[16, 22]. Indeed, some differentiation protocols have shown that
treatment with ActA promotes RPE differentiation [9, 23]. There-
fore, to further direct the cells at prospective eye field stage to-
ward the RPE lineage, we treated cells with ActA to mimic
signaling cues from the extraocular mesenchyme. By day 9, the
cells had become highly confluent; therefore the treatment with
ActA was coupled with dissociation of the cells and replating on
new matrix- coated surfaces. Cells were exposed to 100 ng/ml
ActA (Induction Medium 3) for a period of 19 days (i.e., day 28
postseeding of pluripotent cells). At this point, cobblestone-
shaped cells resembling RPE could be seen in a mixed population
(supplemental online Fig. 2A), and therefore, quantitative poly-
merase chain reaction (PCR) was carried out to measure tran-
script expression of RPE markers. ActA treatment following
replating led to an induction of RPE genes such as Mertk, Pmel,
Tyr, Rlbp1, and Best1 (Fig. 3A). The expression of RPE genes
was similar to levels in mature RPE, derived using an in vitro
Figure 2. Stage 1: induction of eye field from human embryonic stem cells (hESC). (A): Two days’ postseeding, SHEF1 hESC were treated with
Dulbecco’s modified Eagle’s medium KSR-XF alone (Control) or Induction Medium 1 for 4 days, followed by Induction Medium 2 for 3 days
(BMP4/7). Representative images showing immunocytochemistry for the pluripotency marker OCT4 and eye field markers LHX2, SOX11, PAX6,
and MITF are shown. Dotted squares indicate the region that is magnified in the adjacent panels. Images are captured at 310 magnification.
(B):Quantitativepolymerasechain reactionwas carriedout tomeasureexpressionofMitf transcript inSHEF1hESC treatedwith InductionMedium
1 alone (Control) or Induction Medium 1 supplemented with BMP4/7 (50 ng/ml, 100 ng/ml, 200 ng/ml; shown by triangle in order of ascending
concentration); BMP4 (200 ng/ml); or BMP7 (200 ng/ml) (n = 3,6SD). Abbreviation: BMP, bone morphogenetic protein.
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Figure 3. Stage 2: Generation of a mixed RPE population. (A): Two days’ postseeding, SHEF1 human embryonic stem cells were treated with
InductionMedium 1 for 4 days, followed by InductionMedium2 for 3 days. At day 9, cells were replated in Dulbecco’smodified Eagle’smedium
(DMEM) KSR-XF alone (Control) or Induction Medium 3 (ActA) for 19 days. Quantitative polymerase chain reaction was used to measure ex-
pression of a panel of RPE markers. RPE generated by using spontaneous differentiation (Sp. RPE) were used for comparison (n = 3,6SD). (B):
Representative images showing immunocytochemistry for CRALBP and MERTK in cells derived by directed differentiation and cultured as in
panel A. Dotted squares indicate the region that is magnified in the panels below. RPE generated by spontaneous differentiation were used
for comparison. Images are captured at310magnification. (C):Quantification of CRALBP immunocytochemistry at day 28 in which cells during
stage 2 were treated with DMEM KSR-XF (Control) or Induction Medium 3 (ActA) for 3 days, 5 days, 10 days, or 19 days. For fewer than 19-day
ActA treatments, DMEM KSR-XF was used for the remainder of the 19-day period. RPE derived by using spontaneous differentiation (Sp. RPE)
were used for comparison (n = 3,6SD). Abbreviations: ActA, Activin A; d, days; RPE, retinal pigment epithelium; Sp. RPE, spontaneous differ-
entiation retinal pigment epithelium.
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spontaneous differentiation method for RPE generation [18].
These cells used for the purpose of comparison are herein re-
ferred to as “spontaneous RPE.” In order to verify that the tran-
script expression pattern was consistent with protein levels, we
performed immunocytochemistry for MERTK and CRALBP. This
demonstrated that although RPE induction could be detected,
it was not uniform over the entire well (Fig. 3B). Therefore,
RPE cells were present, albeit in a heterogeneous population. A
similar result was seen using SendaiF hiPSC as the starting popu-
lation (supplemental online Fig. 2B). We further demonstrated
that the differentiation process was successful when using mul-
tiple different extracellularmatrices for coating. Inductionof cells
with CRALBP expressionwas observed, regardless ofwhether cells
wereseededonMatrigelorFibronectinduring stage1andreplated
ontoMatrigel or CELLStart during stage 2 (supplemental online Fig.
2C). We also tested the extent of ActA exposure required for RPE
induction.Cells replatedatday9were treatedwithActAfor3,5,10,
or 19 days, and immunocytochemistry was carried out for CRALBP
expression. There was no difference in percentage of CRALBP pos-
itive cells in cultures treated with differing lengths of ActA expo-
sure, indicating that a 3-day exposure was sufficient for RPE
formation (Fig. 3C). This quantification also demonstrated that ap-
proximately 40%–50% of total cells were positive for CRALBP ex-
pression at this stage in comparison with.85% positive expression
in spontaneous RPE, providing further support that RPE cells were
present in a mixed population.
Generation of Functional RPE Cultures Following a
Second Replate Step
Previous reports have suggested that the process of dissociation
and serial replating of mixed RPE cultures leads to purification of
non-RPE cells and the generationof pureRPE cultures [24]. There-
fore,weundertook the approach of passaging theheterogeneous
RPEpopulation generated at day28with a view toward increasing
purity. Immunocytochemistry for mature RPE markers BEST1,
PMEL17, MERTK, CRALBP, and ZO1 was carried out 14 days post-
replating, that is, at day 42 of the protocol. Qualitative analysis of
protein expression showed thepresenceofRPE cellswithhighpu-
rity after this second replating step (Fig. 4A). Similar results were
obtained by using two different hESC (SHEF1 and WA26) and
hiPSC (AD3.1 and SendaiF) cell lines as the starting population,
with cobblestone-shaped morphology (supplemental online
Fig. 3A) and pigmentation typical of RPE cells visible after the sec-
ond replate (supplemental online Fig. 3B). This shows that the di-
rected differentiation method can be broadly applied across
different pluripotent cells.
A key feature of RPE is their capability to polarize and secrete
VEGF and PEDF in a vectorial manner [25, 26]. This polarized se-
cretion of PEDF apically and VEGF basolaterally is an important
characteristic of healthymature RPE cells in vivo. Apical secretion
of PEDF acts to regulate the structural integrity of the retina by
inhibiting invasive choroidal neovascularization, and basolateral
secretion of VEGF, an angiogenic factor, supports the integrity
of the choriocapillaris [2]. Therefore, we tested whether RPE de-
rived with our directed differentiation protocol secreted VEGF
and PEDF in the expected fashion. Cells in stage 3 cultured for
a period of 14 dayswere replated onto transwell inserts to enable
polarization, and spentmediumwas sampled from the apical and
basal compartments to quantify VEGF and PEDF levels. En face
staining of the transwell insert for the tight junction protein
ZO1 showed that the RPE monolayer was confluent and had a
cobblestone-like architecture (Fig. 4B). Measurement of the se-
creted factors at weeks 7 and 10 postseeding showed a (VEGF):
(PEDF) ratio,1 from theapical compartment and.1 in thebasal
compartment (Fig. 4C), indicating higher PEDF secretion apically
and VEGF secretion basolaterally, in keeping with the profile
expected in healthy RPE. Furthermore, the cells were capable
of phagocytosing fluorescently labeled beads (Fig. 4D), which
serves as a surrogatemeasure of ability to phagocytose rod outer
segments [27]. We also observed the formation of dome-shaped
structures in the cell monolayer (supplemental online Fig. 3C),
which is indicative of formation of a cellular barrier and direc-
tional fluid transport by the cells [28] and is another feature of
native RPE. Taken together, these data demonstrate that func-
tional RPE populations can be obtained following the protocol de-
scribed in this study.
Microarray Profiling Reveals Stages of
RPE Development
In order to understand the identity of the cells being produced
during the different phases of the differentiation protocol, we
used microarrays to profile the genome-wide gene expression
levels from cultures atmultiple time points alongside RPE derived
by spontaneous differentiation. Each time point was assayed in
triplicate to understand variability within the protocol.
First, we performed PCA to reveal the relationship between
samples on a global level (Fig. 5A). The close clustering of samples
from the same time point demonstrates the high level of molec-
ular reproducibility produced by the protocol. The first principal
component (PC1) accounts for 27% of the gene expression varia-
tion in the data and appears to correspond largely to the differ-
ence between the differentiating cultures and the spontaneous
RPE samples. Encouragingly, the differentiating samples became
increasingly similar to the spontaneous RPE over time, as mea-
sured by their PC1 score. An alternativemeasure of global sample
similarity is the Pearson’s correlation coefficient (R) of the
genome-wide expression levels. Using this metric, we ob-
served a steady increase in the global similarity over time
within each phase, accompanied by a significant jump in sim-
ilarity during stage 2 and a drop followed by recovery during
stage 3 (Fig. 5B). A potential explanation of this profile is dis-
cussed in the following section.
In order to investigate the expression profiles more closely,
we turnedour attention to theexpressionof genes thatmay serve
asmarkers of different cell populationswithin the in vitro cultures
(Fig. 5C). As was expected, markers of the stem cell phenotype
(e.g., Pou5f1, Nanog, Dnmt3b, Zfp42, and Sall4) were highly
expressed during the early stage of differentiation, and their ex-
pression decreased with time. Treatment with LDN/SB commit-
ted cells toward the ANE and forebrain progenitor state, as is
evidenced by expression of markers such as Irx3, Hesx1, Fgf8,
Otx2, and Pax6 [29–31]. This was followed by expression of eye
field transcription factors such as Six3, Rax, Lhx2, Nr2e1, and
Six6, which have been shown to be essential for induction of
the eye field in several models [32, 33]. Expression of Mab21l2
and Tbx, which are required for formation of the optic vesicle
and optic cup structures [34, 35], further suggests commitment
toward these fates. Finally, we observed expression of genes that
are markers of the RPE fate (e.g., Mitf, Best1, Tyr, Tyrp1, Pmel,
Atp1b1, Dct, and Aldh1a3) during the latter stages of stage 2 as
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well as during stage 3. The expression profile of representative
genes was confirmed by quantitative PCR (supplemental online
Fig. 4). By searching for other geneswith expression patterns cor-
relating withMitf, we identified additional genes that serve as a
good measure of the overall RPE molecular phenotype of cells
within the culture (supplemental online Fig. 5A).
In addition to induction of the RPE fate, we wanted to under-
stand whether there were other non-RPE lineages or cell types
Figure 4. Stage 3: Generation of a homogenous and functional retinal pigment epithelium (RPE) population. (A): Twodays’postseeding, SHEF1
human embryonic stem cells were treated with InductionMedium 1 for 4 days, followed by InductionMedium 2 for 3 days. At day 9, cells were
replated in InductionMedium3for aperiodof 19days. Atday28, cellswere replated inDulbecco’smodifiedEagle’smediumKSR-XFand cultured
for aperiodof 14days. Representative images showing immunocytochemistry for indicatedRPEmarkers are shown. Imagesare capturedat310
magnification. (B): Cells cultured as in panel A were further dissociated and replated on transwells and cultured for a period of 10 weeks. A
representative image showing en face immunocytochemistry for ZO-1 is shown. Images are captured at320magnification. (C): Spentmedium
from transwells described in panel B was collected from the top and bottom chambers and quantified for vascular endothelial growth factor
(VEGF) and pigment epithelium-derived factor (PEDF) concentration. The ratio of [VEGF]:[PEDF] was quantified in media from the two com-
partments (n = 3,6SD). (D): Representative confocal images showing phagocytosis of fluorescent bead (red) by RPE. ZO-1 immunocytochem-
istry (green) shows the cell edge, and the presence of bead within the cell boundary indicates internalization by phagocytosis. Images are
captured at 363 magnification. Abbreviations: PEDF, pigment epithelium-derived factor; VEGF, vascular endothelial growth factor.
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being formed as part of the differentiation process. There-
fore, we looked at the expression of endoderm and meso-
derm markers across the time course of RPE induction as
well as markers characterizing themidbrain and hindbrain re-
gions (Fig. 6A). In comparisonwith expression of RPEmarkers,
we saw little evidence of formation of these other lineages,
indicating that induction toward an eye-specific RPE fate
was taking place. We also examined the expression of
markers of other cell types that originate from the eye field
(e.g., the retina, optic stalk, cornea, lens, and optic nerve)
(Fig. 6B). Expression of Crya transcripts encoding crystallins,
which aremarkers of lens cells [36], could be observed at time
points coinciding with expression of RPE genes. We further
verified this by immunocytochemistry for b-crystallin in
RPE cells at day 48 of the directed differentiation protocol
(Fig. 6C). Quantification of the positive cells showed that in
comparison with .90% RPE measured by expression of
CRALBP, ,10% cells were positive for Crystallin, indicating
that these constituted a minor proportion of the population.
The Crystallin-positive cells were nonproliferative, as is
shown by the absence of Ki67-positive staining (Fig. 6D).
Taken together, these data indicate that directed differenti-
ation toward the RPE lineage may lead to generation of a sub-
population of lens cells.
We were also intrigued by the observation that the initiation
of stage 3 induced a decrease in RPEmarker expression as well as
in the overall molecular profile thatmade the culture temporarily
less RPE-like (Fig. 5B, 5C [RPE genes]). This suggests that the cells
Figure 5. Transcriptome analysis of the directed differentiation protocol. (A, B): Human embryonic stem cells were cultured as de-
scribed in Figure 4A, and samples were collected at different time points of the differentiation protocol. Similarity between samples
at different points of the protocol is shown by principal components analysis (A) and Pearson’s correlation coefficient (B). (C): Micro-
array heatmap showing expression of markers representative of different stages of retinal pigment epithelium differentiation. The
x-axis refers to samples at different time points of directed differentiation. Abbreviations: ANE, anterior neuroectoderm; D, day;
PC1, first principal component; PC2, second principal component; RPE, retinal pigment epithelium; Sp. RPE, RPE generated by spon-
taneous differentiation.
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Figure 6. Specificity and efficiencyof retinal pigment epithelium (RPE) differentiation. (A, B):Microarrayheatmapshowingexpression ofmarkers
representative of different lineages and brain regions (A) and regions of the eye (B). The x-axis refers to samples at different timepoints of directed
differentiation and the Sp. RPE samples refer to RPE generated by spontaneous differentiation. (C, D): Representative images for immunocyto-
chemistry of CRALBP (green) and b-crystallin (red) (C) and Ki67 (green) and b-crystallin (red) (D) are shown. Images are captured at310 magni-
fication. (E):Table summarizingyieldandfoldexpansionofcells atvarious stagesof thedirecteddifferentiationprotocol.Abbreviations:D,day;exp,
expansion; n.a., not applicable; RPE, retinal pigment epithelium; SpRPE, RPE generated by spontaneous differentiation.
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undergo a temporary phase, during which they lose their epithe-
lial phenotype before regaining it during subsequent matura-
tion. This resonates with our previous work demonstrating an
epithelial-mesenchymal-epithelial transition in RPE derived by
spontaneous differentiation [37]. We have shown that when
RPE are dissociated and plated, they undergo a period of prolifer-
ation duringwhich they acquiremesenchymal characteristics and
downregulate expression of epithelial genes. This is followed by a
process of re-epithelialization in which the cells reacquire their
epithelial gene signature. Therefore, we hypothesized that a sim-
ilar phenomenon might be occurring in the RPE cells purified and
replated in stage 3 of directed differentiation. In order to address
this hypothesis, we compared the gene expression profile during
this stage with a dataset generated during dissociation and
expansion of RPE derived fromspontaneous differentiation,which
captures the gene expression profiles during the epithelial-
mesenchymal-epithelial transition [37].We found that the expres-
sion changes observed during the two processes are highly similar
(r = .7; p, 13 10216). Furthermore, a consistent downregulation
of RPE markers such as Mertk, Mitf, Rlbp1, Best1, and Tyr and an
upregulation of mesenchymal markers such as Itga5, Msn, Cav1,
and Serpine1 could be seen in cells during this stage of directed dif-
ferentiation (supplemental online Fig. 5B). This suggests thatwhen
the RPE generated from stage 2 are replated, they undergo an
epithelial-mesenchymal transition-like phenomenon before un-
dergoing re-epithelialization. This is consistentwith thenotion that
the underlying biology and characteristics of the cells are similar,
independentofwhether theyaregeneratedbyspontaneousdiffer-
entiation or directed differentiation.
DISCUSSION
The use of pluripotent stem cell-derived RPE holds great promise
for cell replacement-based therapies for AMD. Since the discov-
ery of spontaneous RPE generation in hESC cultures more than
10 years ago [38], substantial effort has been invested in trying
to develop more efficient RPE differentiation protocols that
allow generation of cells at scale [10]. This is because, although
the spontaneous differentiation method successfully generates
RPE, it is labor intensive and time consuming, requiring manual
excision of pigmented foci, followed by their dissociation and ex-
pansion. Furthermore, limited understanding of how and what
signaling cues lead to RPE generation in this approach makes it
a variable anddifficult-to- control process that is not ideal for clin-
ical application. Several protocols have since been developed to
overcome the limitations of the spontaneous approach. Reports
have described methods such as three-dimensional (3D) cultures
(e.g., neuroepithelial cysts as well as supplementation with
growth factors and small molecules) [19, 23, 39–42]. However,
to our knowledge, no study to date characterizes how themanip-
ulations performed affect the molecular fate and dynamics of
cells developing toward an RPE lineage using methods such as
whole genome transcript analysis. Therefore, although RPE can
be derived in vitro, clear understanding of the underlying stages
of development is lacking.
Here,we describe a simple protocol, without the use of 3D cul-
tureormanual dissection-basedpurificationmethods that leads to
efficientgenerationofRPEwithhighyieldandpurity.Weshowthat
mature, functional RPE canbegenerated in amonolayer culture by
stepwise modulation of Activin A and BMP signaling. Our method
relies on the exogenous supplementation of only four additives:
two small molecules (LDN-193189 and SB-431542) and two
recombinant proteins (BMP4/7 and Activin A) in a temporal and
sequential manner. The use of xeno-free and defined culture me-
dium such as TesR2 or E8 for the culture of pluripotent stem cells
and DMEM KSR-XF for differentiation—together with xeno-free
matricessuchasVitronectin forstemcells,humanplasmaFibronec-
tin for stage 1, and CellSTART for stages 2 and3 of differentiation—
eliminates the use of animal-based or undefined products. Our
method is transferable across different hESC and hiPSC lines and
requiresminimal cell line specificoptimization.Wehavealso tested
its robustness across multiple operators and obtained identical
results. In order to estimate the yield of cells using this protocol,
we have quantified the number of cells obtained at the endof each
phase. A starting culture of 63 106 hESC yields more than 83 108
RPE under the described seeding densities, which is equivalent to
an expansion of approximately 136-fold (Fig. 6E). This can poten-
tially be further increased if seeding densities are altered and the
RPE are expanded through additional passage. This high yield of
cells can be put into better context by considering that a normal
human adult eye contains 4–63 106 RPE [43] and current cell re-
placement therapeutic approaches for treating AMD use a dose of
0.23 106 RPE cells per eye [4]. Therefore, the use of the described
protocol has the potential to sustain manufacturing of the RPE cell
product for treating a large number of patients even when exe-
cuted at a comparatively modest scale, which is advantageous in
terms of keeping the time, labor, and financial outlay as low as
possible.
In addition to developing a robust protocol, we characterize
the cells generated at every stage by performing whole genome
transcript profiling across the time course of induction. This al-
lows us to map the developmental fate of RPE in vitro as well
as define the dynamics of the differentiation process. In doing
so, we validate the role of SMAD inhibition, BMP, and Activin A
pathways in RPE development, and it is extremely encouraging
to note that cells follow a developmental path that would occur
during normal ontogenesis in vivo. Such characterization has
been lacking in all protocols described to date, including spon-
taneous differentiation relying on undefined signaling cues or
directed differentiation using manipulation of signaling path-
ways. As a result, not only is there limited understanding of
the differentiation process itself but also of the identity of
non-RPE “impurities” that might be present remains unknown.
We show that pluripotent cells transition through anterior neu-
roectoderm, eye field, and optic vesicle/cup stages before giving
rise to RPE cells and that there is little evidence to suggest for-
mation of endoderm, mesoderm, midbrain, or hindbrain cell
types. We detect a minor population of Crystallin-positive cells,
indicative of a lens phenotype, being generated together with
RPE. This is not surprising, given that RPE and lens share com-
mon progenitors and RPE are known to transdifferentiate into
lens in certain organisms [44–46]. Our demonstration that these
cells are nonproliferative allays concerns about the presence of
undesirable proliferation in our RPE population, and furtherma-
nipulation of signaling pathways required for lens development
[47] may help to suppress the formation of this cell type. The
transcriptomic analysis presented in this report enables knowl-
edgeofmarkers that are expressed at specific timepoints,which
can be used to design in-process controls for a manufacturing
process or enable quality-by-design strategies for process devel-
opment. Furthermore, the two replating steps at day 9 and day
28 offer potential opportunities to introduce cryopreservation
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steps that can offer ameans to pause the differentiation process
or allow a window to sample cells for quality control, both of
which are desirable attributes for developing cell products. Fi-
nally, we note that the gene expression analysis indicates that
the level of expression of RPE genes is higher in cells derived
from spontaneous differentiation in comparison with directed
differentiation. This may be due to the much longer time scales
of spontaneous differentiation, which can be around 4–6months
postseeding pluripotent cells, followed by purification bymanual
excision and expansion. This may not be directly comparable to
RPEderivedbydirecteddifferentiation,whichmaybeat anearlier
stage of terminal differentiation and have not undergone addi-
tional purification to remove non-RPE cells for, as an example,
the Crystallin-positive lens-type cells as identified in our study.
Further work comparing the function of RPE derived from spon-
taneousanddirecteddifferentiation in an invivo setting is needed
to clarify whether the difference in gene expression translates to
a difference in quality or function.
In summary, we show that we can efficiently direct pluripo-
tent stem cells toward retinal pigment epithelium fate by using
a simple directed differentiation method. The high-yield, short-
time scale, and xeno-free culture conditions make it adaptable
for useunderGMPconditions for clinical applications. In addition,
it can be applied to generate RPE for screening, modeling of ret-
inal pathophysiologies, and further understanding of the AMD
diseased state, potentially opening up more avenues for thera-
peutic intervention.
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